Description
Amlodipine 10 mg Tablets is available by prescription only. Go ahead and place your purchase. After making payment, we will ensure that a valid prescription is received from your prescriber.
Drug Label Highlights
These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS.
AMLODIPINE BESYLATE tablets, for oral administration
Initial U.S. Approval: 1992
Indications And Usage
Amlodipine besylate tablet, USP is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:
o Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
o Chronic Stable Angina
o Vasospastic Angina (Prinzmetal's or Variant Angina)
o Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%
Dosage And Administration
o Small, fragile, or elderly patients or patients with hepatic insufficiency may be started on 2.5 mg once daily. (2.1)
Important Limitation: Doses in excess of 5 mg daily have not been studied in pediatric patients. (2.2)
Dosage Forms And Strengths
Contraindications
Warnings And Precautions
- Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis. However, acute hypotension is unlikely. (5.1)
- Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of Amlodipine besylate, particularly in patients with severe obstructive coronary artery disease. (5.2)
- Titrate slowly in patients with severe hepatic impairment. (5.3)
Adverse Reactions
Most common adverse reaction to amlodipine is edema which occurred in a dose related manner. Other adverse experiences not dose related but reported with an incidence >1.0% are fatigue, nausea, abdominal pain, and somnolence. (6)
To report SUSPECTED ADVERSE REACTIONS, contact Cipla Limited, India at 1-866-604-3268 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Drug Interactions
Use In Specific Populations
See 17 for FDA-approved patient labeling.
Revised: 2/2024
DailyMed highlights last updated: 2026-06-24 22:21:06









Reviews
There are no reviews yet.